HopeStage
Back to all studies
CompletedNCT01170117

Olanzapine Compared With Placebo for Anorexia Nervosa

About this title

Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa

Read the official source — NCT01170117
Medication studyAges 18–75United States + CanadaEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

What did participation involve?

Depending on the group, the protocol specifies the study medication (olanzapine) or a placebo (an inactive comparison treatment).

Listed locations
Baltimore and 4 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 2010
Recruitment status
Completed
Enrollment listed in the registry
152
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Locations
United States, Canada
Age range
From 18 Years to 75 Years
Official registry ID
NCT01170117
Official title
Show the full official title

Olanzapine vs Placebo for Outpatients With Anorexia Nervosa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore, United States · New York, United States · White Plains, United States

2 more locations
  • Pittsburgh, United States
  • Toronto, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine and Placebo.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies